Literature DB >> 22914595

A simple echocardiographic prediction rule for hemodynamics in pulmonary hypertension.

Alexander R Opotowsky1, Jason Ojeda, Frances Rogers, Vikram Prasanna, Mathieu Clair, Lilamarie Moko, Anjali Vaidya, Jonathan Afilalo, Paul R Forfia.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) has diverse causes with heterogeneous physiology compelling distinct management. Differentiating patients with primarily elevated pulmonary vascular resistance (PVR) from those with PH predominantly because of elevated left-sided filling pressure is critical. METHODS AND
RESULTS: We reviewed hemodynamics, echocardiography, and clinical data for 108 patients seen at a referral PH clinic with transthoracic echocardiogram and right heart catheterization within 1 year. We derived a simple echocardiographic prediction rule to allow hemodynamic differentiation of PH attributed to pulmonary vascular disease (PH(PVD), defined as pulmonary artery wedge pressure [PAWP]≤15 mm Hg and PVR>3 WU). Age averaged 61.3±14.8 years, μPAWP and PVR were 16.4±7.1 mm Hg and 6.3±4.0 WU, respectively, and 52 (48.1%) patients fulfilled PH(PVD) hemodynamic criteria. The derived prediction rule ranged from -2 to +2 with higher scores suggesting higher probability of PH(PVD): +1 point for left atrial anterior-posterior dimension <3.2 cm; +1 for presence of a mid systolic notch or acceleration time <80 ms; -1 for lateral mitral E:e'>10; -1 for left atrial anterior-posterior dimension >4.2 cm. PVR increased stepwise with score (for -2, 0, and +2, μPVR were 2.5, 4.5, and 8.1 WU, respectively), whereas the inverse was true for pulmonary artery wedge pressure (corresponding μPAWP were 21.5, 16.5, and 10.4 mm Hg). Among subjects with complete data, the score had an area under the curve (AUC) of 0.921 for PH(PVD). A score ≥0 had 100% sensitivity and 69.3% positive predictive value for PH(PVD), with 62.3% specificity. No patients with a negative score had PH(PVD). Patients with a negative score and acceleration time >100 ms had normal PVRPVR=1.8 WU, range=0.7-3.2 WU).
CONCLUSIONS: We present a simple echocardiographic prediction rule that accurately defines PH hemodynamics, facilitates improved screening and focused clinical investigation for PH diagnosis and management.

Entities:  

Mesh:

Year:  2012        PMID: 22914595      PMCID: PMC3505751          DOI: 10.1161/CIRCIMAGING.112.976654

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  31 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

2.  Clinical application of tissue Doppler imaging in patients with idiopathic pulmonary hypertension.

Authors:  Qinyun Ruan; Sherif F Nagueh
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

3.  Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography.

Authors:  Howard J Willens; Julio A Chirinos; Orlando Gomez-Marin; Debra P Fertel; Reyan A Ghany; Carlos E Alfonso; Joshua M Hare
Journal:  J Am Soc Echocardiogr       Date:  2008-03-06       Impact factor: 5.251

4.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

5.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

6.  Pulmonary arterial pressure can be estimated by transesophageal pulsed doppler echocardiography.

Authors:  S Kawahito; H Kitahata; K Tanaka; J Nozaki; S Oshita
Journal:  Anesth Analg       Date:  2001-06       Impact factor: 5.108

7.  Proximal pulmonary emboli modify right ventricular ejection pattern.

Authors:  A Torbicki; M Kurzyna; M Ciurzynski; P Pruszczyk; R Pacho; A Kuch-Wocial; M Szulc
Journal:  Eur Respir J       Date:  1999-03       Impact factor: 16.671

8.  Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.

Authors:  Robert P Frantz; Raymond L Benza; Barbro Kjellström; Robert C Bourge; Robyn J Barst; Tom D Bennett; Michael D McGoon
Journal:  J Heart Lung Transplant       Date:  2008-06-02       Impact factor: 10.247

9.  Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation.

Authors:  Ramin Farzaneh-Far; Barry H McKeown; Dan Dang; John Roberts; Nelson B Schiller; Elyse Foster
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

10.  Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension.

Authors:  Nedim Selimovic; Bengt Rundqvist; Claes-Hakan Bergh; Bert Andersson; Sofia Petersson; Lena Johansson; Odd Bech-Hanssen
Journal:  J Heart Lung Transplant       Date:  2007-09       Impact factor: 10.247

View more
  39 in total

Review 1.  The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series).

Authors:  Alexis Harrison; Nathan Hatton; John J Ryan
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 2.  Assessment of right ventricular function in pulmonary hypertension.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 3.  Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management.

Authors:  Nehal Hussain; Athanasios Charalampopoulos; Sheila Ramjug; Robin Condliffe; Charlie A Elliot; Laurence O'Toole; Andrew Swift; David G Kiely
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 4.  Hemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertension.

Authors:  Bradley A Maron
Journal:  Can J Cardiol       Date:  2014-09-28       Impact factor: 5.223

5.  Improving on the diagnostic characteristics of echocardiography for pulmonary hypertension.

Authors:  Kathleen Broderick-Forsgren; Clemontina A Davenport; Joseph A Sivak; Charles William Hargett; Michael C Foster; Andrew Monteagudo; Alicia Armour; Sudarshan Rajagopal; Kristine Arges; Eric J Velazquez; Zainab Samad
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-24       Impact factor: 2.357

6.  Pulmonary Artery Acceleration Time Provides a Reliable Estimate of Invasive Pulmonary Hemodynamics in Children.

Authors:  Philip T Levy; Meghna D Patel; Georgeann Groh; Swati Choudhry; Joshua Murphy; Mark R Holland; Aaron Hamvas; Mark R Grady; Gautam K Singh
Journal:  J Am Soc Echocardiogr       Date:  2016-09-15       Impact factor: 5.251

Review 7.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14

8.  Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial.

Authors:  Bradley A Maron; Ronald H Goldstein; Sharon I Rounds; Shelley Shapiro; Matthew Jankowich; Eric Garshick; Marilyn L Moy; David Gagnon; Gaurav Choudhary
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 9.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

10.  Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients.

Authors:  Bradley A Maron; Gaurav Choudhary; Umar A Khan; Matthew D Jankowich; Hope McChesney; Sarah J Ferrazzani; Sainath Gaddam; Satish Sharma; Alexander R Opotowsky; Deepak L Bhatt; Thomas P Rocco; Jayashri R Aragam
Journal:  Circ Heart Fail       Date:  2013-06-27       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.